EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Human leucocyte antigen‐matched related haematopoietic stem cell transplantation using low‐dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia

Abdulrahman Alsultan iD, Rodaina Abujoub, Reem Alsudairy, Shahbaz Memon, Mohammad S Jarrar, Sameera Alafghani, Saad Aldaama, Walid Ballourah, Fahd Almanjomi, Mohammed F Essa iD

British Journal of Haematology · 2023

DOI: 10.1111/bjh.19004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2023. Verfasst von Abdulrahman Alsultan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Anemia, Aplastic, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Fanconi Anemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When human leucocyte antigen‐matched related donors are available, haematopoietic stem cell transplantation (HSCT) in children with severe aplastic anaemia (SAA) represents the standard of care. Cyclophosphamide (Cy) 200 mg/kg and anti‐thymocyte globulin (ATG) are frequently administered, but to‐date, no standard conditioning regimen exists. In this study, we investigated the efficacy of a unified HSCT conditioning protocol consisting of low‐dose Cy 80 mg/kg, fludarabine and ATG. Data were reviewed from children aged ≤14 years with either acquired SAA or non‐Fanconi anaemia inherited bone marrow failure syndrome (IBMFS) between 2011 and 2022 at various Saudi institutions. Graft‐versus‐host disease (GVHD) prophylaxis included mycophenolate mofetil and calcineurin inhibitors. HSCT was performed in 32 children (17 females and 15 males). Nine patients had deleterious mutations (two ERCC6L2 , two ANKRD26 , two TINF2 , one LZTFL1 , one RTEL1 and one DNAJC21 ). Four patients had short telomeres. All 32 patients engrafted successfully. At 3 years post‐transplant, the event‐free survival was 93% and overall survival was 95%. Two patients experienced secondary graft failure or myelodysplastic syndrome. A low probability of GVHD was observed (one acute GVHD II and one mild chronic GVHD). These data highlight how HSCT using low‐dose Cy as part of a fludarabine‐based regimen is safe and effective in SAA/non‐Fanconi anaemia IBMFS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticHematopoietic Stem Cell TransplantationGraft vs Host DiseaseFanconi AnemiaMaleFemaleHumansChildAntilymphocyte SerumCongenital Bone Marrow Failure SyndromesCyclophosphamideHLA AntigensHistocompatibility Antigens Class IITransplantation ConditioningDNA HelicasesVidarabine

Stichwörter der Autor:innen

aplastic anaemiachildrencyclophosphamideinherited bone marrow failure syndromesstem cell transplantation

Substanzen

Antilymphocyte SerumCyclophosphamideHLA AntigensHistocompatibility Antigens Class IIDNA HelicasesthymoglobulinfludarabineVidarabineERCC6L2 protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Oncology Center, King Saud University Medical City, Riyadh, Saudi Arabia.
  • Department of Pediatric Hematology/Oncology and Stem Cell Transplantation, Comprehensive Cancer Center, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Department of Nursing, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Department of Pediatric Hematology/Oncology, King Abdullah Specialist Children's Hospital, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Schulich School of Medicine, University of Western Ontario, London, Ontario, Canada.

ORCID-Profile: Abdulrahman Alsultan, Mohammed F Essa

Zitieren

APA

Alsultan, A., Abujoub, R., Alsudairy, R., Memon, S., Jarrar, M. S., Alafghani, S., Aldaama, S., Ballourah, W., Almanjomi, F., & Essa, M. F. (2023). Human leucocyte antigen‐matched related haematopoietic stem cell transplantation using low‐dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.19004

Vancouver

Alsultan A, Abujoub R, Alsudairy R, Memon S, Jarrar MS, Alafghani S, et al. Human leucocyte antigen‐matched related haematopoietic stem cell transplantation using low‐dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia. British Journal of Haematology. 2023. doi:10.1111/bjh.19004

BibTeX
@article{Alsultan2023,
  author = {Alsultan, Abdulrahman and Abujoub, Rodaina and Alsudairy, Reem and Memon, Shahbaz and Jarrar, Mohammad S and Alafghani, Sameera and Aldaama, Saad and Ballourah, Walid and Almanjomi, Fahd and Essa, Mohammed F},
  title = {Human leucocyte antigen‐matched related haematopoietic stem cell transplantation using low‐dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia},
  journal = {British Journal of Haematology},
  year = {2023},
  doi = {10.1111/bjh.19004}
}
Kostenlos starten →